West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 344,500 | 339,400 | 321,500 | 303,800 | 324,800 |
| Cost of Goods | 233,600 | 227,700 | 224,000 | 213,400 | 226,100 |
| Gross Profit | 110,900 | 111,700 | 97,500 | 90,400 | 98,700 |
| Operating Expenses | 69,000 | 69,100 | 66,000 | 64,500 | 63,200 |
| Operating Income | 42,500 | 43,300 | 31,500 | 26,300 | 35,600 |
| Interest Expense | 4,100 | 4,600 | 3,400 | 4,400 | 4,600 |
| Other Income | 2,100 | 1,600 | 400 | 1,900 | -8,900 |
| Pre-tax Income | 40,500 | 40,300 | 28,500 | 23,800 | 22,100 |
| Income Tax | 10,300 | 8,600 | 7,400 | 9,000 | 6,500 |
| Net Income Continuous | 30,200 | 31,700 | 21,100 | 14,800 | 15,600 |
| Net Income | $30,200 | $31,700 | $21,100 | $14,800 | $15,600 |
| EPS Basic Total Ops | 0.44 | 0.46 | 0.31 | 0.22 | 0.23 |
| EPS Basic Continuous Ops | 0.43 | 0.46 | 0.31 | 0.22 | 0.23 |
| EPS Diluted Total Ops | 0.43 | 0.45 | 0.31 | 0.21 | 0.23 |
| EPS Diluted Continuous Ops | 0.43 | 0.45 | 0.30 | 0.21 | 0.21 |
| EBITDA(a) | $63,200 | $63,800 | $51,700 | $45,600 | $54,400 |